Keyword: Contract Development And Manufacturing Organizations (CDMO)

Strategy & Management

Pharma: Adapting to an Ever-Changing Environment

19.09.2018 - At Chemoutsourcing conference 2017, Jean-Jacques (John) Mondoloni, Managing Partner at Wombat Capital, chaired and moderated a round table on the topic “How Is The M&A Rush Shaking...

Plant Construction & Process Technology

Winning Strategies in the Pharmaceutical CDMO Industry

19.09.2018 - Despite the favorable economic environment, the global economic risk factors have intensified against the background of record global debt and a rise in geopolitical risk. Amid...

Plant Construction & Process Technology

East or West? East and West!

31.08.2018 - Outsourcing is about the efficiencies of globalization, expense, people, and the challenge of drug discovery. Big Pharma has consolidated and faltered over the past 15 to 20 years...

News

Cambrex to Acquire Halo Pharma

25.07.2018 - Cambrex, a US-based small molecule innovator and developer of generic Active Pharmaceutical Ingredients (APIs), has agreed to acquire compatriot Contract Development and...

News

CatSci Appoints Paul Bradley as Head of Business Development

28.06.2018 - CatSci, a UK-based process research and development contract research organization, announced the appointment of Paul Bradley as its new head of business development. Bradley joins...

News

Celonic: Soenke Brunswieck appointed as Vice President Cell & Gene Therapy

26.06.2018 - Swiss biologics CDMO Celonic has appointed Soenke Brunswieck as VP cell & gene therapy to establish the organization’s new portfolio of CDMO services in the cell and gene therapy...

Chemistry & Life Sciences

Addressing Challenges in Sterile Manufacturing

30.03.2018 - With a market value of $62 billion in 2016, the contract development and manufacturing organization (CDMO) industry has a compound annual growth rate (CAGR) of 6-7 %, according to...

Strategy & Management

Lonza Adds More Building Blocks for the Healthcare Continuum

27.02.2018 - Contract development and manufacturing organization (CDMO) Lonza said it exceeded its full-year 2017 guidance. The company reported sales of CHF 5.1 billion. Having closed the...